5-amino-1mq chemical structure or formula 5-Amino-1MQ 5mg - Prime Peptide

doi:10.1016/j.bcp.2024.116476 Evidence-Base Disclosure The published evidence base for 5-Amino-1MQ consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments

Epigenetic and Cellular Reprogramming: By blocking NNMT-mediated methylation of nicotinamide, preserves NAD salvage pathway activity, increases SIRT-1 signaling, reduces histone deacetylation, and promotes metabolic reprogramming toward oxidative phosphorylation and glycolysis balance, supporting tissue repair and energy homeostasis 1-4

It also helps to reduce the risk of developing heart attack, dementia, and stroke, since it decreases homocysteine levels

Recent surgery

The information provided here is not a substitute for professional medical advice, diagnosis, or treatment